indazoles has been researched along with Lymphoma, Large B-Cell, Diffuse in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abraham, MJ; Del Rincón, SV; Dupéré-Richer, D; Emond, A; Johnson, NA; Kinal, M; Licht, JD; Mann, KK; Miller, WH; Pettersson, F; Preston, SEJ; Riva, A; Rys, RN | 1 |
| Junghanss, C; Kong, W; Murua Escobar, H; Nolte, I; Perez, SV; Ruetgen, B; Sekora, A; Sender, S | 1 |
| Cai, Y; Han, Y; Hu, S; Liu, J; Ren, S; Wang, X; Yang, J; Zhao, Y; Zhou, X | 1 |
| Assouline, S; Burke, JM; Chen, R; Essell, J; Patel-Donnelly, D; Sharman, J; Shi, W; Shustov, A; Yang, J; Ye, W | 1 |
| Bertoni, F; Bujisic, B; Chelbi, S; De Gassart, A; Demaria, O; Gilliet, M; Martinon, F; Tallant, R; Zaffalon, L | 1 |
| Albom, MS; Angeles, TS; Ator, MA; Becknell, NC; Cheng, M; Dorsey, BD; Holskin, BP; Hudkins, RL; Lu, L; Meyer, SL; Quail, MR; Reddy, DR; Ruggeri, BA; Underiner, TL; Wan, W; Weinberg, LR | 1 |
1 trial(s) available for indazoles and Lymphoma, Large B-Cell, Diffuse
| Article | Year |
|---|---|
An Open-label, Phase II Trial of Entospletinib (GS-9973), a Selective Spleen Tyrosine Kinase Inhibitor, in Diffuse Large B-cell Lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Disease Progression; Drug Administration Schedule; Female; Humans; Indazoles; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Progression-Free Survival; Protein Kinase Inhibitors; Pyrazines; Syk Kinase; Time Factors | 2018 |
5 other study(ies) available for indazoles and Lymphoma, Large B-Cell, Diffuse
| Article | Year |
|---|---|
Acquired Resistance to EZH2 Inhibitor GSK343 Promotes the Differentiation of Human DLBCL Cell Lines toward an ABC-Like Phenotype.
Topics: Cell Line, Tumor; Drug Resistance, Neoplasm; Enhancer of Zeste Homolog 2 Protein; Humans; Indazoles; Lymphoma, Large B-Cell, Diffuse; Phenotype; Pyridones | 2022 |
Pan- and Isoform-specific Inhibition of the Bromodomain and Extra-terminal Proteins and Evaluation of Synergistic Potential With Entospletinib in Canine Lymphoma.
Topics: Animals; Cell Line, Tumor; Dogs; Heterocyclic Compounds, 2-Ring; Heterocyclic Compounds, 4 or More Rings; Indazoles; Lymphoma, Large B-Cell, Diffuse; Nuclear Proteins; Piperazines; Protein Isoforms; Protein Serine-Threonine Kinases; Pyrazines; Pyrazoles; Pyridazines; Syk Kinase | 2020 |
Inhibition of Polo-like kinase 4 induces mitotic defects and DNA damage in diffuse large B-cell lymphoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; DNA Damage; Doxorubicin; Female; Gene Expression Regulation, Neoplastic; Humans; Indazoles; Indoles; Lymphoma, Large B-Cell, Diffuse; Mice, SCID; Mitosis; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Signal Transduction; Tumor Burden; Xenograft Model Antitumor Assays | 2021 |
Impairment of both IRE1 expression and XBP1 activation is a hallmark of GCB DLBCL and contributes to tumor growth.
Topics: Animals; B-Lymphocytes; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Endoribonucleases; Enhancer of Zeste Homolog 2 Protein; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Germinal Center; Histones; Humans; Indazoles; Leupeptins; Lymphoma, Large B-Cell, Diffuse; Mice; Mice, 129 Strain; Plasma Cells; Promoter Regions, Genetic; Protein Serine-Threonine Kinases; Pyridones; RNA, Messenger; Signal Transduction; X-Box Binding Protein 1; Xenograft Model Antitumor Assays | 2017 |
Anaplastic lymphoma kinase activity is essential for the proliferation and survival of anaplastic large-cell lymphoma cells.
Topics: Anaplastic Lymphoma Kinase; Apoptosis; Carbazoles; Caspases; Cell Division; Cell Line, Tumor; Cell Survival; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Indazoles; Lymphoma, Large B-Cell, Diffuse; Phenylurea Compounds; Protein-Tyrosine Kinases; Receptor Protein-Tyrosine Kinases | 2006 |